Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver
Clinical trial NCT02724540 · COMPLETED
Trial details
- NCT number
- NCT02724540
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2024-04-30
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.